d3bio.org Logo
  • About D3Bio
    • D3Bio’s Commitment
    • D3Bio Advisory Board
    • D3Bio Supporters
    • OTEF
    • OTEF Leadership
    • Privacy Policy
  • D3Bio News
    • AZ Pipeline
  • Programs
    • Internship Opportunities
  • Resources
    • AZBio.TV
    • Arizona BioMap
    • Arizona Bioindustry Fact Sheet
  • Contact D3Bio
  • Donate
  • Menu

Tag Archives: ALK and EML4

TGen study identifies gene fusion as likely cause of rare type of thyroid cancer

Posted on March 19, 2014January 13, 2018 by D3Bio

Genomic sequencing of 62-year-old patient leads to new treatment optionContinue reading→

D3Bio Events

  • No events
  • all events

Disclaimer
Privacy Policy
Cookie Policy (EU)
Cookie Policy (UK)
Do Not Sell My Personal Information

© D3Bio 2021